Atinvicitinib
Product Specifications
CAS Number
2169273-59-8
Target
JAK
Related Pathways
JAK/STAT signaling|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||Angiogenesis|||Stem Cells
Purity
0.9936
Bioactivity
Atinvicitinib, a selective Janus kinase (JAK) inhibitor, demonstrates high specificity for Janus kinase 1 (JAK1), consequently inhibiting downstream cytokine signaling pathways that rely on JAK1 enzymatic activity. Atinvicitinib modulates a wide range of cytokines that are implicated in itch responses, allergic reactions, and inflammatory conditions, making it a significant research tool for studying cytokine-mediated immune processes as well as therapeutic modulation of allergic and inflammatory diseases.
Smiles
COc1cc(Nc2nn(cc2C(N)=O)[C@H]2COCC[C@@H]2C#N)cc(F)n1
Molecular Formula
C16H17FN6O3
Molecular Weight
360.35
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx146159-01 100 µg
LON Peptidase N-Terminal Domain And RING Finger Protein 1 (LONRF1) Antibody
Ask
View Details 
abx146159-02 1 mg
LON Peptidase N-Terminal Domain And RING Finger Protein 1 (LONRF1) Antibody
Ask
View Details 
129462-ML490 100 µL
MBD1 (Methyl-CpG-binding Domain 1, PCM1, Methyl-CpG-binding Protein MBD1, Protein Containing Methyl-CpG-binding Domain 1, CXXC-type Zinc Finger Protein 3, CXXC3, PCM1) (MaxLight 490)
Ask
View Details ![WDR68 Recombinant Rabbit Monoclonal Antibody [JE61-64]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea81a92/imageurl/ha720062.webp)